{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:53:42Z","timestamp":1782957222502,"version":"3.54.5"},"reference-count":60,"publisher":"American Association for Cancer Research (AACR)","issue":"12","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015338","name":"HHS | NIH | NCI | Cancer Moonshot","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100015338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Understanding of tumor biology and identification of effective therapies is lacking for many rare tumors. My Pediatric and Adult Rare Tumor (MyPART) network was established to engage patients, advocates, and researchers and conduct a comprehensive longitudinal Natural History Study of Rare Solid Tumors. Through remote or in-person enrollment at the NIH Clinical Center, participants with rare solid tumors \u22654 weeks old complete standardized medical and family history forms, patient reported outcomes, and provide tumor, blood and\/or saliva samples. Medical records are extracted for clinical status and treatment history, and tumors undergo genomic analysis. A total of 200 participants (65% female, 35% male, median age at diagnosis 43 years, range = 2\u201377) enrolled from 46 U.S. states and nine other countries (46% remote, 55% in-person). Frequent diagnoses were neuroendocrine neoplasms (NEN), adrenocortical carcinomas (ACC), medullary thyroid carcinomas (MTC), succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (sdGIST), and chordomas. At enrollment, median years since diagnosis was 3.5 (range = 0\u201336.6), 63% participants had metastatic disease and 20% had no evidence of disease. Pathogenic germline and tumor mutations included SDHA\/B\/C (sdGIST), RET (MTC), TP53 and CTNNB1 (ACC), MEN1 (NEN), and SMARCB1 (poorly-differentiated chordoma). Clinically significant anxiety was observed in 20%\u201335% of adults. Enrollment of participants and comprehensive data collection were feasible. Remote enrollment was critical during the COVID-19 pandemic. Over 30 patients were enrolled with ACC, NEN, and sdGIST, allowing for clinical\/genomic analyses across tumors. Longitudinal follow-up and expansion of cohorts are ongoing to advance understanding of disease course and establish external controls for interventional trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study demonstrates that comprehensive, tumor-agnostic data and biospecimen collection is feasible to characterize different rare tumors, and speed progress in research. The findings will be foundational to developing external controls groups for single-arm interventional trials, where randomized control trials cannot be conducted because of small patient populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0247","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T08:54:31Z","timestamp":1700038471000},"page":"2468-2482","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1148-9415","authenticated-orcid":true,"given":"Shadin","family":"Ahmed","sequence":"first","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9707-7175","authenticated-orcid":true,"given":"Mary Frances","family":"Wedekind","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9710-4030","authenticated-orcid":true,"given":"Jaydira","family":"Del Rivero","sequence":"additional","affiliation":[{"name":"2Developmental Therapeutics Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6590-7926","authenticated-orcid":true,"given":"Margarita","family":"Raygada","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2736-660X","authenticated-orcid":true,"given":"Robin","family":"Lockridge","sequence":"additional","affiliation":[{"name":"3Clinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, Frederick, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-7876","authenticated-orcid":true,"given":"John W.","family":"Glod","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7252-4778","authenticated-orcid":true,"given":"Crystal","family":"Flowers","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9614-9347","authenticated-orcid":true,"given":"BJ","family":"Thomas","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7490-7231","authenticated-orcid":true,"given":"Donna B.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6540-7292","authenticated-orcid":true,"given":"Oxana B.","family":"Kapustina","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8190-2978","authenticated-orcid":true,"given":"Ashish","family":"Jain","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."},{"name":"4Research Computing, Department of Information Technology, Boston Children's Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3282-8107","authenticated-orcid":true,"given":"Markku","family":"Miettinen","sequence":"additional","affiliation":[{"name":"5Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4039-6957","authenticated-orcid":true,"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[{"name":"5Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5033-7072","authenticated-orcid":true,"given":"Liqiang","family":"Xi","sequence":"additional","affiliation":[{"name":"5Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8087-0542","authenticated-orcid":true,"given":"Manoj","family":"Tyagi","sequence":"additional","affiliation":[{"name":"5Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9023-6276","authenticated-orcid":true,"given":"Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"5Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-7550","authenticated-orcid":true,"given":"Kenneth","family":"Aldape","sequence":"additional","affiliation":[{"name":"5Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4442-7343","authenticated-orcid":true,"given":"Ashkan A.","family":"Malayeri","sequence":"additional","affiliation":[{"name":"6Department of Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8580-0001","authenticated-orcid":true,"given":"Rosandra N.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7661-1380","authenticated-orcid":true,"given":"Taryn","family":"Allen","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."},{"name":"3Clinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, Frederick, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7305-7468","authenticated-orcid":true,"given":"Christina A.","family":"Vivelo","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."},{"name":"7Kelly Government Solutions, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0630-4205","authenticated-orcid":true,"given":"Abby B.","family":"Sandler","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-7175","authenticated-orcid":true,"given":"Brigitte C.","family":"Widemann","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9109-4409","authenticated-orcid":true,"given":"Karlyne M.","family":"Reilly","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the MyPART network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"2023120614023043100_bib1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.chembiol.2017.08.002","article-title":"Emerging opportunities for target discovery in rare cancers","volume":"24","author":"Sharifnia","year":"2017","journal-title":"Cell Chem Biol"},{"key":"2023120614023043100_bib2","doi-asserted-by":"crossref","first-page":"e28993","DOI":"10.1002\/pbc.28993","article-title":"Facing the challenges of very rare tumors of pediatric age: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) background, goals, and achievements","volume":"68","author":"Ferrari","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"2023120614023043100_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.08.021","article-title":"Statistical genomics in rare cancer","volume":"61","author":"Abbas-Aghababazadeh","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"2023120614023043100_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/CCI.19.00085","article-title":"CART-WHEEL.org: an ethically approved online database for patient-entered data to facilitate rare cancer research","volume":"4","author":"Kee","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"key":"2023120614023043100_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MOP.0000000000000857","article-title":"Challenges and solutions to the study of rare childhood tumors","volume":"32","author":"Fair","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"2023120614023043100_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41591-019-0749-z","article-title":"The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research","volume":"26","author":"Painter","year":"2020","journal-title":"Nat Med"},{"key":"2023120614023043100_bib7","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/S1470-2045(15)00388-5","article-title":"The value of research collaborations and consortia in rare cancers","volume":"17","author":"Blay","year":"2016","journal-title":"Lancet Oncol"},{"key":"2023120614023043100_bib8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1470-2045(17)30445-X","article-title":"Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study","volume":"18","author":"Gatta","year":"2017","journal-title":"Lancet Oncol"},{"key":"2023120614023043100_bib9","doi-asserted-by":"crossref","first-page":"100846","DOI":"10.1016\/j.neo.2022.100846","article-title":"The children's brain tumor network (CBTN) \u2013 accelerating research in pediatric central nervous system tumors through collaboration and open science","volume":"35","author":"Lilly","year":"2023","journal-title":"Neoplasia"},{"key":"2023120614023043100_bib10","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-19-3356","article-title":"A phase II Basket Trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART SWOG 1609) in patients with nonpancreatic neuroendocrine tumors","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2023120614023043100_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1470-2045(12)70570-3","article-title":"International rare cancers initiative","volume":"14","author":"Keat","year":"2013","journal-title":"Lancet Oncol"},{"key":"2023120614023043100_bib12","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.21.02838","article-title":"Actionable tumor alterations and treatment protocol enrollment of pediatric and young adult patients with refractory cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial","volume":"40","author":"Parsons","year":"2022","journal-title":"J Clin Oncol"},{"key":"2023120614023043100_bib13","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/1078-0432.CCR-22-0803","article-title":"Upfront biology-guided therapy in diffuse intrinsic pontine glioma: therapeutic, molecular, and biomarker outcomes from PNOC003","volume":"28","author":"Kline","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2023120614023043100_bib14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.celrep.2019.09.071","article-title":"Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design","volume":"29","author":"Rokita","year":"2019","journal-title":"Cell Rep"},{"key":"2023120614023043100_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature25795","article-title":"Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours","volume":"555","author":"Ma","year":"2018","journal-title":"Nature"},{"key":"2023120614023043100_bib16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1126\/science.aai7862","article-title":"A U.S. Cancer Moonshot\" to accelerate cancer research","volume":"353","author":"Singer","year":"2016","journal-title":"Science"},{"key":"2023120614023043100_bib17","doi-asserted-by":"crossref","first-page":"e30495","DOI":"10.1002\/pbc.30495","article-title":"NCI intramural program approach to rare tumors: Natural History Study of Rare Solid Tumors in children and adults: a longitudinal, comprehensive data and biospecimen collection protocol","author":"Wedekind","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"2023120614023043100_bib18","unstructured":"Office of the Commissioner Office of Clinical Policy and Programs, Office of Orphan Products Development, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Rare diseases: natural history studies for drug development: draft guidance for industry. March 2019. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/rare-diseases-natural-history-studies-drug-development."},{"key":"2023120614023043100_bib19","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N Engl J Med"},{"key":"2023120614023043100_bib20","doi-asserted-by":"crossref","first-page":"100769","DOI":"10.1016\/j.currproblcancer.2021.100769","article-title":"Using real world data to support regulatory approval of drugs in rare diseases: a review of opportunities, limitations & a case example","volume":"45","author":"Gross","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"2023120614023043100_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.annonc.2021.12.015","article-title":"External control arms in oncology: current use and future directions","volume":"33","author":"Mishra-Kalyani","year":"2022","journal-title":"Ann Oncol"},{"key":"2023120614023043100_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2023120614023043100_bib23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","article-title":"Body-mass index and mortality in a prospective cohort of U.S. adults","volume":"341","author":"Calle","year":"1999","journal-title":"N Engl J Med"},{"key":"2023120614023043100_bib24","article-title":"Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960\u20131962 through 2017\u20132018","author":"Fryar","year":"2020"},{"key":"2023120614023043100_bib25","article-title":"National health and nutrition examination survey 2017\u2013March 2020 prepandemic data files\u2014development of files and prevalence estimates for selected health outcomes","author":"Stierman","year":"2021"},{"key":"2023120614023043100_bib26","article-title":"BC Cancer Pharmacy Education Program Cancer Drug Pharmacology Table. Pharmacology_Table.pdf","author":"Kalyn","year":"2018"},{"key":"2023120614023043100_bib27","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1007\/s11136-014-0732-6","article-title":"Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment","volume":"23","author":"Cella","year":"2014","journal-title":"Qual Life Res"},{"key":"2023120614023043100_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41687-020-0181-7","article-title":"Development and validation of an interpretive guide for PROMIS scores","volume":"4","author":"Rothrock","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"2023120614023043100_bib29","doi-asserted-by":"crossref","first-page":"268ra177","DOI":"10.1126\/scitranslmed.3009961","article-title":"Recurrent epimutation of SDHC in gastrointestinal stromal tumors","volume":"6","author":"Killian","year":"2014","journal-title":"Sci Transl Med"},{"key":"2023120614023043100_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/14737140.8.4.625","article-title":"RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer","volume":"8","author":"Lodish","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"2023120614023043100_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0042-1754316","article-title":"Trigeminal nerve melanotic schwannoma in carney complex","volume":"32","author":"Sharath","year":"2022","journal-title":"Indian J Radiol Imaging"},{"key":"2023120614023043100_bib32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41586-022-04809-8","article-title":"The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer","volume":"606","author":"Patel","year":"2022","journal-title":"Nature"},{"key":"2023120614023043100_bib33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00345-012-1011-1","article-title":"Adrenal tumours are more predominant in females regardless of their histological subtype: a review","volume":"31","author":"Audenet","year":"2013","journal-title":"World J Urol"},{"key":"2023120614023043100_bib34","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.3748\/wjg.v21.i8.2303","article-title":"Succinate dehydrogenase-deficient gastrointestinal stromal tumors","volume":"21","author":"Wang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2023120614023043100_bib35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1089\/thy.2020.0167","article-title":"Predicting outcomes in sporadic and hereditary medullary thyroid carcinoma over two decades","volume":"31","author":"Kotwal","year":"2021","journal-title":"Thyroid"},{"key":"2023120614023043100_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1186\/s12885-020-07178-5","article-title":"Education level as a predictor of survival in patients with multiple myeloma","volume":"20","author":"Xu","year":"2020","journal-title":"BMC Cancer"},{"key":"2023120614023043100_bib37","doi-asserted-by":"crossref","first-page":"e6641","DOI":"10.1097\/MD.0000000000006641","article-title":"Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: A nationwide, multicenter 10-year epidemiological study","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"key":"2023120614023043100_bib38","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1080\/14740338.2021.1939672","article-title":"The effect of patient sex on the efficacy and safety of anticancer immunotherapy","volume":"20","author":"Pala","year":"2021","journal-title":"Expert Opin Drug Saf"},{"key":"2023120614023043100_bib39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"key":"2023120614023043100_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12889-017-4375-8","article-title":"Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review","volume":"17","author":"Hann","year":"2017","journal-title":"BMC Public Health"},{"key":"2023120614023043100_bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21637","article-title":"Cancer statistics for adolescents and young adults","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"2023120614023043100_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1878-0261.12417","article-title":"Early-onset colorectal cancer in young individuals","volume":"13","author":"Mauri","year":"2019","journal-title":"Mol Oncol"},{"key":"2023120614023043100_bib43","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamaoncol.2016.0256","article-title":"Molecular subtypes of KIT\/PDGFRA wild-type gastrointestinal stromal tumors: a report from the National Institutes of Health gastrointestinal stromal tumor clinic","volume":"2","author":"Boikos","year":"2016","journal-title":"JAMA Oncol"},{"key":"2023120614023043100_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1200\/JCO.2016.68.6733","article-title":"Surgical management of wild-type gastrointestinal stromal tumors: a report from the National Institutes of Health pediatric and wildtype GIST clinic","volume":"35","author":"Weldon","year":"2017","journal-title":"J Clin Oncol"},{"key":"2023120614023043100_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30358","article-title":"The NIH pediatric\/young adult chordoma clinic and natural history study: making advances in a very rare tumor","author":"John","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"2023120614023043100_bib46","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1200\/JCO.22.02208","article-title":"The Childhood Cancer Data Initiative: using the power of data to learn from and improve outcomes for every child and young adult with pediatric cancer","volume":"41","author":"Flores-Toro","year":"2023","journal-title":"J Clin Oncol"},{"key":"2023120614023043100_bib47","first-page":"61","article-title":"Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Health Serv Insights"},{"key":"2023120614023043100_bib48","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.15585\/mmwr.mm6650a1","article-title":"Prevalence of obesity among adults, by household income and education\u2014United States, 2011\u20132014","volume":"66","author":"Ogden","year":"2017","journal-title":"MMW Morb Mortal Wkly Rep"},{"key":"2023120614023043100_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a Children's Oncology Group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J Clin Oncol"},{"key":"2023120614023043100_bib50","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2147\/OTT.S159979","article-title":"beta-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion","volume":"11","author":"Liu","year":"2018","journal-title":"Onco Targets Ther"},{"key":"2023120614023043100_bib51","first-page":"6072863","article-title":"Molecular drivers of potential immunotherapy failure in adrenocortical carcinoma","author":"Fiorentini","year":"2019","journal-title":"J Oncol"},{"key":"2023120614023043100_bib52","doi-asserted-by":"crossref","first-page":"17588359211023278","DOI":"10.1177\/17588359211023278","article-title":"Targeted therapy in SDH-deficient GIST","volume":"13","author":"Nannini","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"2023120614023043100_bib53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/a-1145-8479","article-title":"Update on the treatment of medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2","volume":"52","author":"Ilanchezhian","year":"2020","journal-title":"Horm Metab Res"},{"key":"2023120614023043100_bib54","doi-asserted-by":"crossref","first-page":"708949","DOI":"10.3389\/fendo.2021.708949","article-title":"Update on targeted therapy in medullary thyroid cancer","volume":"12","author":"Okafor","year":"2021","journal-title":"Front Endocrinol"},{"key":"2023120614023043100_bib55","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1158\/1078-0432.CCR-17-2101","article-title":"Outcomes of children and adolescents with advanced hereditary medullary thyroid carcinoma treated with vandetanib","volume":"24","author":"Kraft","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2023120614023043100_bib56","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00401-010-0767-x","article-title":"Loss of SMARCB1\/INI1 expression in poorly differentiated chordomas","volume":"120","author":"Mobley","year":"2010","journal-title":"Acta Neuropathol"},{"key":"2023120614023043100_bib57","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ng.454","article-title":"T (brachyury) gene duplication confers major susceptibility to familial chordoma","volume":"41","author":"Yang","year":"2009","journal-title":"Nat Genet"},{"key":"2023120614023043100_bib58","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"key":"2023120614023043100_bib59","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/neuonc\/noz108","article-title":"Germline genetic landscape of pediatric central nervous system tumors","volume":"21","author":"Muskens","year":"2019","journal-title":"Neuro Oncol"},{"key":"2023120614023043100_bib60","doi-asserted-by":"crossref","first-page":"107062","DOI":"10.1016\/j.ypmed.2022.107062","article-title":"Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: Estimates from the 2015 National Health Interview Survey","volume":"159","author":"Kumerow","year":"2022","journal-title":"Prev Med"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0247\/3382222\/crc-23-0247.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/12\/2468\/3388546\/crc-23-0247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/12\/2468\/3388546\/crc-23-0247.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T09:04:59Z","timestamp":1701853499000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/12\/2468\/731520\/Longitudinal-Natural-History-Study-of-Children-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,6]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0247","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.24756488.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756491","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756506.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756485","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756497","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756461","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756491.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756494.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756473","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756467","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756485.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756500","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756479","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756455","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756452.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756506","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756497.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756455.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756470","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756482","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756458.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756470.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756452","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756464","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756494","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756461.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756467.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756476","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756488","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756458","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756503","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756464.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756476.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756500.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756482.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756473.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756503.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24756479.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.6968086","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6968086.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}